Filter by patients with: All

What is Pancrelipase?

Category: Prescription Drugs

Most popular types: Creon Creon 24 Zenpep Show all

false

Pancrelipase is an enzyme used for the treatment of exocrine pancreatic insufficiency (EPI) due to conditions such as cystic fibrosis. It is also used for the treatment of blocked feeding tubes.

See patients taking Pancrelipase

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Pancreatitis 43 13
Cystic fibrosis 42 8
Support digestive health 27 7
Pancreatic insufficiency 22 11
Hereditary chronic pancreatitis 5 2
Autoimmune pancreatitis 2 2

Show all 22 reasons taken

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
See all 169 patients that have taken Pancrelipase

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 1
Moderate 3
Mild 13
None 24

Commonly reported side effects and conditions associated with Pancrelipase

Side effect Patients Percentage
Abdominal cramps 2
Constipation 2
Nausea 2
Abdominal bloating 1
Chronic diarrhea 1
Diarrhea 1

Show all 14 reported side effects

Dosages

Based on patients currently taking Pancrelipase

Dosage Patients Percentage
2 capsule(s) three times daily 2
24,000-17,000-5,000 unt twice daily 1
2 x 30,000-19,000-6,000 unt three times daily 1
60,000-38,000-12,000 unt three times daily 1
120,000-76,000-24,000 unt three times daily 1
120,000-76,000-24,000 unt four times daily 1
8 x 15,000-9,500-3,000 unt four times daily 1
2 x 120,000-76,000-24,000 unt three times daily 1
2 x 168,000-126,000-40,000 unt three times daily 1
3 x 180,000-114,000-36,000 unt three times daily 1

See all 13 dosages

Why patients stopped taking Pancrelipase

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 6
Other 6
Did not seem to work 4
Course of treatment ended 1
Expense 1
Side effects too severe 1
See all 13 patients who've stopped taking Pancrelipase

Duration

Currently taking Pancrelipase

Duration Patients Percentage
1 - 6 months 1
1 - 2 years 1
2 - 5 years 6
5 - 10 years 5
10 years or more 1

Stopped taking Pancrelipase

Duration Patients Percentage
Less than 1 month 1
1 - 6 months 3
2 - 5 years 4
5 - 10 years 2
10 years or more 3
Adherence
Adherence Evaluations Percentage
Always 23
Usually 9
Sometimes 7
Never taken as prescribed 2
Burden
Burden Evaluations Percentage
Very hard to take 4
Somewhat hard to take 7
A little hard to take 8
Not at all hard to take 22
Cost per month
Cost per month Evaluations Percentage
$200+ 4
$100-199 1
$50-99 1
$25-49 3
< $25 14
Not specified 18

What people switch to and from

Patients started taking Pancrelipase after stopping:

Treatment Patients Percentage
Pancrelipase (Creon) 2

Patients stopped taking Pancrelipase and switched to:

Treatment Patients Percentage
Pancrelipase (Creon) 2
Last updated:
There are no evaluations for Pancrelipase.